share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

輝瑞 | 4:持股變動聲明-董事 NARAYEN SHANTANU
美股SEC公告 ·  07/01 20:49
Moomoo AI 已提取核心訊息
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on June 28, 2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Narayen is located at 66 Hudson Boulevard East, New York, NY. Without further details on the transaction, investors are advised to seek additional information to understand the potential impact on their investment decisions regarding Pfizer stock.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on June 28, 2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Narayen is located at 66 Hudson Boulevard East, New York, NY. Without further details on the transaction, investors are advised to seek additional information to understand the potential impact on their investment decisions regarding Pfizer stock.
輝瑞公司[PFE]的報告人Shantanu Narayen於2024年6月28日參與了一次交易,交易的具體細節,如操作類型、狀態幣、涉及股數、股份性質、交易價格和參股金融後的持股情況,在公告中未披露。Narayen提供的地址位於紐約州紐約市東66街哈德遜大道66號。在交易的更多細節未披露的情況下,建議投資者尋求更多信息,以了解輝瑞股票的潛在影響,並做出投資決策。
輝瑞公司[PFE]的報告人Shantanu Narayen於2024年6月28日參與了一次交易,交易的具體細節,如操作類型、狀態幣、涉及股數、股份性質、交易價格和參股金融後的持股情況,在公告中未披露。Narayen提供的地址位於紐約州紐約市東66街哈德遜大道66號。在交易的更多細節未披露的情況下,建議投資者尋求更多信息,以了解輝瑞股票的潛在影響,並做出投資決策。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息